1
|
Park S, Ahn G, Hong J, Seo S. A case of veiled onychomatricoma. J Eur Acad Dermatol Venereol 2019; 33:e420-e422. [DOI: 10.1111/jdv.15740] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- S.J. Park
- Department of Dermatology Chung‐Ang University College of Medicine Seoul South Korea
| | - G.R. Ahn
- Department of Dermatology Chung‐Ang University College of Medicine Seoul South Korea
| | - J.Y. Hong
- Department of Dermatology Chung‐Ang University College of Medicine Seoul South Korea
| | - S.J. Seo
- Department of Dermatology Chung‐Ang University College of Medicine Seoul South Korea
| |
Collapse
|
2
|
[Proximal subungual onychomycosis in a patient treated with tumor necrosis factor alpha blockers]. Semergen 2016; 43:245-246. [PMID: 27436820 DOI: 10.1016/j.semerg.2016.06.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2016] [Revised: 05/31/2016] [Accepted: 06/02/2016] [Indexed: 11/21/2022]
|
3
|
Abstract
Background Onychomycosis has several clinical presentations and is caused by various infectious organisms. Objective To provide guidance for selection of appropriate treatment. Methods The literature on onychomycosis management was reviewed to generate an evidence-based decision tree. Results and Conclusion Several options are available: terbinafine, itraconazole, fluconazole, ciclopirox 8% nail lacquer, efinaconazole 10% nail solution, and laser therapy. Further studies on lasers are needed before use can be recommended. Nondermatophyte molds or mixed infection can be managed with terbinafine or itraconazole with or without topicals. Itraconazole, fluconazole, and efinaconazole can be used for Candida infection. For dermatophytes, topicals can be considered for mild to moderate onychomycosis. For moderate to severe cases, any oral monotherapy can be used; however, we suggest terbinafine if there is a possibility of a drug interaction. These recommendations can be applied for all ages, immune function, or metabolic status, but proper monitoring and contraindications should be taken into consideration.
Collapse
Affiliation(s)
- Aditya K. Gupta
- From the Department of Medicine, University of Toronto, Toronto, ON, and Mediprobe Research Inc., London, ON
| | - Maryse Paquet
- From the Department of Medicine, University of Toronto, Toronto, ON, and Mediprobe Research Inc., London, ON
| |
Collapse
|